|
The latest editiion of IJPC is now online! Get a free digital sample, search 25 years of content, and subscribe today to IJPC - The only journal solely dedicated to the art and science of pharmaceutical compounding!
Selected Articles Preview
|
New Drug Approvals 2022 and Compounding Opportunities
Loyd V. Allen, Jr., PhD, RPh, Editor-in-Chief, IJPC
As new drugs come on the market, many of those drugs offer opportunities for compounding to make them more
suitable for specific patients. A list of the new drugs that have been approved in 2022 is provided, along with their compounding potentials.
|
|
Compounding for the Treatment of COVID-19 and Long COVID, Part 1: Terminology, Mutations, and Variants
Mike Riepl RPh, Retired Compounding Pharmacist
This article, a first in a series on compounding for COVID-19 and long COVID (i.e., the long-term sequelae of SARS-CoV-2 infection), provides information about pertinent viral terminology and a brief overview of SARS-CoV-2 mutations and variants of note. Two formulations for customized compounds that may prove effective in treating the acute and/or long-term effects of COVID-19 when commercial therapies have failed are also provided.
|
|
How to Know if Your Cleanroom Can Consistently Operate Within a State of Control
Amy Summers, PharmD, BCSCP; Pat Stephens, PharmD, CQA, Restore Health Consulting
Whether sterile compounds are prepared in a brand new state-of-the-art cleanroom suite or in an aging space, compounders rely heavily on their primary and secondary engineering controls when sterilizing or maintaining sterility of the final preparation.
|
Table of Contents
Complete contents, abstracts, page previews, and subscriber downloads are available on the
IJPC Issue Page.
FEATURE ARTICLES
Formulations: Case Report: Anal Fissures and Hemorrhoids Treated with Compounded Cromolyn Sodium and Naltrexone Hydrochloride in MEDISCA's SPG SUPPOSI-BASE
Clinical Compounding: Compounding for the Treatment of COVID-19 and LONG COVID, Part 1: Terminology, Mutations, and Variants
Legislative | Regulatory: The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
APPLIED COMPOUNDING
Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature, and Quality Control of Microneedle Arrays
Sterile Basics of Compounding: How to Know if Your Cleanroom Can Consistently Operate Within a State of Control
Basics of Compounding: A Review: In Situ Gel Dosage Forms for Herbal Medicine Delivery
PEER REVIEWED
Formulative Study: Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals and Comparison of Ibuprofen Nanocrystals Tablets with Conventional Market Product
Stability Study: Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base
Formulative Study: Design and Development of Agglomerated Isomalt
FORMULATIONS
Acetaminophen 10 mg/mL for Rectal Use
Clozapine 20 mg-mL in Ora-Sweet and Ora-Plus
Dapsone 2 mg-mL in Ora-Sweet and Ora-Plus
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus
Manning's Liniment
Mayer's Ointment
Povidone Iodine 100-mg/mL Solution/Spray
Psoriasis Topical Ointment
Suspension Solution, Sugar Free
DEPARTMENTS
Editorial/Prescription: New Drug Approvals 2022 and Compounding Opportunities
Calculations: Uses of the abbreviation “q.s.�
|
